Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sidransky

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Screening for clonal genetic alterationsD Sidransky
Annual Review of Medicine|January 1, 1996
Clinical implications of the p53 geneD Sidransky, M Hollstein
The Urologic Clinics of North America|November 1, 1992
Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factorsD Sidransky, E Messing
Biochimica Et Biophysica Acta|April 24, 1999
Molecular methods for the diagnosis of cancerP Cairns, D Sidransky
Human Molecular Genetics|March 1, 1994
Tetranucleotide repeat polymorphism in RAF1L Mao, D Sidransky
Cancer Research|April 1, 1994
Cancer screening based on genetic alterations in human tumorsL Mao, D Sidransky
The American Journal of Pathology|December 1, 1996
Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellitesG Steiner, D Sidransky
Experimental Cell Research|March 10, 2001
p16(MTS-1/CDKN2/INK4a) in cancer progressionJ W Rocco, D Sidransky
Journal of the National Cancer Institute|October 28, 1998
Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodilesW H Westra, D Sidransky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Role of the p16 tumor suppressor gene in cancerW H Liggett, D Sidransky
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Screening for clonal genetic alterationsD Sidransky
Annual Review of Medicine|January 1, 1996
Clinical implications of the p53 geneD Sidransky, M Hollstein
The Urologic Clinics of North America|November 1, 1992
Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factorsD Sidransky, E Messing
Biochimica Et Biophysica Acta|April 24, 1999
Molecular methods for the diagnosis of cancerP Cairns, D Sidransky
Human Molecular Genetics|March 1, 1994
Tetranucleotide repeat polymorphism in RAF1L Mao, D Sidransky
Cancer Research|April 1, 1994
Cancer screening based on genetic alterations in human tumorsL Mao, D Sidransky
The American Journal of Pathology|December 1, 1996
Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellitesG Steiner, D Sidransky
Experimental Cell Research|March 10, 2001
p16(MTS-1/CDKN2/INK4a) in cancer progressionJ W Rocco, D Sidransky
Journal of the National Cancer Institute|October 28, 1998
Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodilesW H Westra, D Sidransky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Role of the p16 tumor suppressor gene in cancerW H Liggett, D Sidransky
Pageof 21